Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,667 | 0 | N/A | 0 | 0 |
| TOTAL | $18,189 | $0 | $N/A | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 258 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 30 | 0 | 0 | 0 | 0 |
| TOTAL | $288 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $18,477 | $0 | $N/A | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,728 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 778 | 0 | N/A | 0 | 0 |
| Other current liabilities | 35 | 0 | N/A | 0 | 0 |
| TOTAL | $2,541 | $0 | $N/A | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,541 | $0 | $N/A | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 163 | N/A | N/A | N/A | N/A |
| Retained earnings | -41,102 | 0 | N/A | 0 | 0 |
| Other shareholders' equity | 41,835 | 0 | 0 | 0 | 0 |
| TOTAL | $15,936 | $0 | $N/A | $0 | $0 |
| Total Liabilities And Equity | $18,477 | $0 | $0 | $0 | $0 |